Literature DB >> 6682639

Role of a natriuretic factor in essential hypertension: an hypothesis.

M P Blaustein, J M Hamlyn.   

Abstract

Excessive dietary intake of sodium appears to play a significant role in human essential hypertension. The underlying mechanism may involve the excessive secretion of a humoral natriuretic factor in response to the salt load. Deproteinized plasma from patients with essential hypertension contains elevated levels of an ouabain-like inhibitor of dog kidney sodium plus potassium-dependent adenosine triphosphatase. This substance, by inhibiting renal sodium transport, should have a natriuretic effect. Plasma from hypertensive patients also produces an ouabain-like sensitization of vascular smooth muscle (rabbit aorta) to exogenous norepinephrine. These data suggest that a circulating inhibitor of the sodium pump may play a key role in generating increased peripheral vascular resistance. Cellular mechanisms that link sodium pump inhibition to increased vascular resistance involve increased norepinephrine release and reduced re-uptake and directly increased smooth muscle contractility and reactivity, as a result of increased cell sodium.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6682639     DOI: 10.7326/0003-4819-98-5-785

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

Review 1.  Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.

Authors:  A Clerico; G Mariani
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

Review 2.  Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium, and calcium regulation.

Authors:  A Aviv; M Aladjem
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

3.  Race and sex differences in erythrocyte Na+, K+, and Na+-K+-adenosine triphosphatase.

Authors:  N Lasker; L Hopp; S Grossman; R Bamforth; A Aviv
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

4.  Effect of inhibition of Na+/K(+)-adenosine triphosphatase on vascular action of vasopressin.

Authors:  K Okada; C Caramelo; P Tsai; R W Schrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 5.  Fetal endoxins and complications of pregnancy.

Authors:  R C Goodlin; E L Makowski
Journal:  West J Med       Date:  1988-05

Review 6.  Management of essential hypertension in the black patient: profiling as the initial approach to treatment.

Authors:  F H Messerli
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798

7.  Sodium and hypertension. Still a controversy in 1986.

Authors:  E A Francischetti; V G de Abreu Fagundes; W Oigman
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 8.  The Renin-Angiotensin System in the Development of Salt-Sensitive Hypertension in Animal Models and Humans.

Authors:  Beate Rassler
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-29

9.  Erythrocyte Na(+)-K+ ATPase activity in the genesis of reducing renal mass in hypertensive rats.

Authors:  Y S Yoon; B K Bang; B S Min; H J Kim
Journal:  Korean J Intern Med       Date:  1986-07       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.